These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28978318)

  • 1. Interpretation of microbiota-based diagnostics by explaining individual classifier decisions.
    Eck A; Zintgraf LM; de Groot EFJ; de Meij TGJ; Cohen TS; Savelkoul PHM; Welling M; Budding AE
    BMC Bioinformatics; 2017 Oct; 18(1):441. PubMed ID: 28978318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust Microbiota-Based Diagnostics for Inflammatory Bowel Disease.
    Eck A; de Groot EFJ; de Meij TGJ; Welling M; Savelkoul PHM; Budding AE
    J Clin Microbiol; 2017 Jun; 55(6):1720-1732. PubMed ID: 28330889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD.
    Casén C; Vebø HC; Sekelja M; Hegge FT; Karlsson MK; Ciemniejewska E; Dzankovic S; Frøyland C; Nestestog R; Engstrand L; Munkholm P; Nielsen OH; Rogler G; Simrén M; Öhman L; Vatn MH; Rudi K
    Aliment Pharmacol Ther; 2015 Jul; 42(1):71-83. PubMed ID: 25973666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.
    Khanna S; Vazquez-Baeza Y; González A; Weiss S; Schmidt B; Muñiz-Pedrogo DA; Rainey JF; Kammer P; Nelson H; Sadowsky M; Khoruts A; Farrugia SL; Knight R; Pardi DS; Kashyap PC
    Microbiome; 2017 May; 5(1):55. PubMed ID: 28506317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ada-WHIPS: explaining AdaBoost classification with applications in the health sciences.
    Hatwell J; Gaber MM; Atif Azad RM
    BMC Med Inform Decis Mak; 2020 Oct; 20(1):250. PubMed ID: 33008388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modulation of the intestinal microbiota by nutritional interventions].
    Derer S; Lehnert H; Sina C; Wagner AE
    Internist (Berl); 2017 May; 58(5):435-440. PubMed ID: 28283691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic evaluation of supervised classifiers for fecal microbiota-based prediction of colorectal cancer.
    Ai L; Tian H; Chen Z; Chen H; Xu J; Fang JY
    Oncotarget; 2017 Feb; 8(6):9546-9556. PubMed ID: 28061434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoding the language of microbiomes using word-embedding techniques, and applications in inflammatory bowel disease.
    Tataru CA; David MM
    PLoS Comput Biol; 2020 May; 16(5):e1007859. PubMed ID: 32365061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistent metagenomic biomarker detection via robust PCA.
    Alshawaqfeh M; Bashaireh A; Serpedin E; Suchodolski J
    Biol Direct; 2017 Jan; 12(1):4. PubMed ID: 28143486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taxonomy-aware feature engineering for microbiome classification.
    Oudah M; Henschel A
    BMC Bioinformatics; 2018 Jun; 19(1):227. PubMed ID: 29907097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease.
    Schulberg J; De Cruz P
    Intern Med J; 2016 Mar; 46(3):266-73. PubMed ID: 26968595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.
    Putignani L; Del Chierico F; Vernocchi P; Cicala M; Cucchiara S; Dallapiccola B;
    Inflamm Bowel Dis; 2016 Feb; 22(2):487-504. PubMed ID: 26588090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease.
    Chehoud C; Albenberg LG; Judge C; Hoffmann C; Grunberg S; Bittinger K; Baldassano RN; Lewis JD; Bushman FD; Wu GD
    Inflamm Bowel Dis; 2015 Aug; 21(8):1948-56. PubMed ID: 26083617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal Microbiota Transplantation in Inflammatory Bowel Disease.
    Reinisch W
    Dig Dis; 2017; 35(1-2):123-126. PubMed ID: 28147375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients.
    Matijašić M; Meštrović T; Perić M; Čipčić Paljetak H; Panek M; Vranešić Bender D; Ljubas Kelečić D; Krznarić Ž; Verbanac D
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota and IBD: causation or correlation?
    Ni J; Wu GD; Albenberg L; Tomov VT
    Nat Rev Gastroenterol Hepatol; 2017 Oct; 14(10):573-584. PubMed ID: 28743984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
    Serban DE
    Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders.
    Lopetuso LR; Petito V; Graziani C; Schiavoni E; Paroni Sterbini F; Poscia A; Gaetani E; Franceschi F; Cammarota G; Sanguinetti M; Masucci L; Scaldaferri F; Gasbarrini A
    Dig Dis; 2018; 36(1):56-65. PubMed ID: 28683448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.